WilliamHill¹Ù·½ÍøÕ¾

ÐÂÎŶ¯Ì¬

Á×Ö¬õ£Ë¿°±Ë᣺ҽѧÓëÓªÑøÑ§ÖеÄË«ÖØÓ¦ÓÃ
·ÖÀà £ºÐÂÎÅ
Ðû²¼Ê±¼ä £º2024/06/07
»á¼ûÁ¿ £º26

ÔÚÕæºËϸ°ûÖÐ £¬Ö¬ÖÊÔÚÉúÎïĤÉϵÄÂþÑܾßÓÐ²î³Ø³ÆÐÔ¡£Ïêϸ¶øÑÔ £¬ÇÊÌÇÖ¬¡¢ÇÊÁ×Ö¬ºÍÁ×Ö¬õ£µ¨¼îµÈÖ÷ÒªÂþÑÜÔÚϸ°ûĤÍâ²à £¬¶ø°±»ùÁ×Ö¬ÈçÁ×Ö¬õ£ÒÒ´¼°·ºÍÁ×Ö¬õ£Ë¿°±ËᣨPS£©Ö÷ÒªÂþÑÜÔÚϸ°ûÄڲࡣPSÊÇÒ»ÀàÓɳ¤Á´Ö¬·¾Ëá £¬¸ÊÓ͹ǼܺÍÁ×֬ͷ»ù×é³ÉµÄ»¯ºÏÎï £¬½á¹¹Í¨Ê½¼ûÏÂͼ£º


ͼ1.png

ͼһ Á×Ö¬õ£Ë¿°±ËáµÄ½á¹¹Í¨Ê½


Á×Ö¬õ£Ë¿°±Ëá×÷ÎªÕæºËϸ°ûÖк¬Á¿×î¸ßµÄÒõÀë×ÓÁ×Ö¬ £¬Ô¼Õ¼Ï¸°û×ÜÖ¬ÖʵÄ10% £¬¶Ôµ÷ÖÎϸ°ûĤµÄÁ÷¶¯ÐÔºÍͨ͸ÐÔ¾ßÓÐÒªº¦×÷Óà £¬²¢ÇÒÄܼ¤»î¶àÖÖøÀàµÄ´úлºÍºÏ³É¡£±ðµÄ £¬PS¹ØÓÚ¸ÄÉÆÉñ¾­Ï¸°û¹¦Ð§ £¬µ÷ÀíÉñ¾­ÐźÅת´ïºÍÔö½ø´óÄÔÓ°Ïó¹¦Ð§¾ßÓÐÆð¾¢Ó°Ïì¡£


ÈËÌåÄܹ»×ÔÖ÷ºÏ³ÉPS £¬Í¬Ê±Ò²¿ÉÒÔͨ¹ýʳÎïµÈÍⲿ;¾¶»ñÈ¡¡£ÔÚ´óÄÔÉñ¾­Ï¸°ûµÄĤ½á¹¹ÖÐ £¬PSµÄŨ¶ÈÓÈΪͻ³ö £¬ÆäÔÚĤÉÏµÄ²î³Ø³ÆÂþÑܹØÓÚά³Öϸ°ûÕý³£ÐÄÀí¹¦Ð§ÖÁ¹ØÖ÷Òª¡£


ÔÚ¿µ½¡Ï¸°ûÖÐ £¬PS¼ÓÈëÄýѪÀú³Ì £¬³É¼¡Ï¸°ûÈÚºÏÒÔ¼°TÁܰÍϸ°û»î»¯µÈ¶àÖÖÐÄÀí¹¦Ð§¡£ËüÊÇϸ°ûµòÍöµÄÆæÒìÌØÕ÷ £¬Äܹ»ÎªÏ¸°ûµòÍöÌṩ¿Éʶ±ðºÍ¿ÉÇø·ÖµÄÐźÅ¡£ÔÚ¿µ½¡Ï¸°ûÖÐ £¬PSλÓÚϸ°ûĤÄÚ²à £¬¶øµ±Ï¸°û×îÏȵòÍöʱ £¬PS»á´Óϸ°ûĤµÄÄڲ෭תµ½Ï¸°ûĤµÄÍâò £¬Ì»Â¶ÓÚ°ûÍâÇéÐÎÖÐ £¬´Ó¶ø×÷ΪµòÍöϸ°ûµÄÐźŠ£¬±»¾ÞÊÉϸ°ûÖбí´ïµÄPSÊÜÌåʶ±ð²¢É¨³ý¡£


ÔÚÖ×Áö΢ÇéÐÎÖÐ £¬PSÔÚÖ×Áöϸ°ûºÍÃâÒßϸ°ûÍâòµÄ̻¶ÓëÃâÒßÒÖÖÆºÍÖ×ÁöÉú³¤µÄÔö½øÓÐ¹Ø £¬Òò´Ë £¬PSÔÚϸ°ûĤÉϵÄλÖùØÓÚϸ°ûµÄ´æ»î¡¢Éú³¤¡¢ÔöÖ³ÒÔ¼°°©Ö¢Ïà¹ØÖ¢×´¾ßÓÐÖØ´óÒâÒå¡£


°ÐÏòPS±»ÒÔΪÊǰ©Ö¢ÖÎÁƵÄÒ»ÖÖÓÐǰ;µÄÕ½ÂÔ £¬½üÄêÀ´ £¬¿ÆÑ§¼ÒÃÇÒѾ­¿ª·¢³ö¶àÖÖ°ÐÏòPSµÄÒ©Îï £¬ÓÃÓÚ°©Ö¢ÖÎÁÆ¡£ÔÚÁÙ´²ÊÔÑéÖÐ £¬°ÍάÍ×Îôµ¥¿¹×÷Ϊ¼òµ¥Ò©Îï»òÓëÆäËû¹Å°åÖÎÁÆÒªÁìÍŽáÓ¦Óà £¬Òѱ»Ö¤ÊµÔÚÖÎÁƷΰ©¡¢¸Îϸ°û°©¡¢ÈéÏÙ°©¡¢ÒÈÏÙ°©ºÍÆäËûʵÌåÁö·½Ãæ¾ßÓÐÁÆÐ§ £¬²¢ÇÒ±¬·¢µÄ¸±×÷ÓÃÏà¶Ô½ÏÉÙ¡£±ðµÄ £¬°ÍάÍ×Îôµ¥¿¹ÓëË÷À­·ÇÄáÍŽáÖÎÁƸÎϸ°û°© £¬ÒÔ¼°Ó뼪Î÷Ëû±õÍŽáÖÎÁÆÒÈÏÙ°© £¬Ò²Õ¹ÏÖ³öÁËÏÔÖøµÄÖÎÁÆÐ§¹û¡£ÕâЩ·¢Ã÷Ϊ°©Ö¢ÖÎÁÆ¿ª·¢ÁËеĿÉÄÜÐÔ¡£³ý´ËÖ®Íâ £¬¿¹ÌåżÁªÒ©Îï £¬Ö¬ÖÊÌåÔØÌåÒ²ÊÇDZÔÚµÄÓÃÓÚÖÎÁÆÖ×ÁöµÄ°ÐÏòPSÕ½ÂÔ¡£


ÔÚÉñ¾­ÉúÎïѧÁìÓò £¬PSÔÚÉñ¾­Ï¸°ûĤÖк¬Á¿¸»ºñ £¬¶ÔÉñ¾­Ï¸°ûµÄ´æ»î¡¢ÐÞ¸´ºÍ¹¦Ð§Ê©Õ¹ÖÁ¹ØÖ÷Òª¡£PSÔÚÖÐÊàÉñ¾­ÏµÍ³ÖеÄÖ÷Òª×÷ÓðüÀ¨Ôö½ø¶à°Í°·µÄÊÍ·Å £¬ÔöÌíÉñ¾­µÝÖÊÒÒõ£µ¨¼îµÄÌìÉú £¬ÌáÉýÄÔÆÏÌÑÌÇ´úлЧÂÊ £¬½µµÍÇ⻯¿ÉµÄËÉˮƽ £¬ÒÔ¼°ÔöÇ¿Éñ¾­Éú³¤Òò×ӵĻîÐԵȡ£Òò´Ë £¬PSÔÚ¶àÖÖÖÐÊàÉñ¾­ÏµÍ³¼²²¡ÖÐÊÎÑÝ×ÅÖ÷Òª½ÇÉ« £¬Õ⺭¸ÇÁ˰¢¶û´Äº£Ä¬²¡¡¢ÅÁ½ðÉ­²¡¡¢ÒÖÓôÖ¢¡¢È±ÑªÐÔÖз硢×Ô±ÕÖ¢¡¢×¢ÖØÁ¦È±ÏݶදÕϰ­¡¢¾«ÉñÆÆËéÖ¢ÒÔ¼°¼¹ËèËðÉ˵Ȳ¡Ö¢¡£


Ëæ×ÅÄêËêÔöÌí £¬´óÄÔÖе¨¹Ì´¼Ë®Æ½ÉÏÉý¶øÁ×Ö¬õ£Ë¿°±ËᣨPS£©º¬Á¿Ï½µ £¬Õâ»áµ¼Ö´óÄÔϸ°ûÄÚø»îÐÔÏ÷Èõ¡¢Ï¸°ûÔËÊäÄÜÁ¦½µµÍÒÔ¼°Í»´¥ÅþÁ¬ïÔÌ­ £¬×îÖÕÒýÆðÓ°ÏóÁ¦¼õÍË¡£°¢¶û´Äº£Ä¬²¡£¨AD£©ÊÇÒ»ÖÖÂýÐÔÉñ¾­ÍËÐÐÐÔ¼²²¡ £¬ÊÇÍíÄê³Õ´ô֢ϵÁÐ×î³£¼ûµÄÒ»ÖÖ¼²²¡¡£Ïà¹ØÁÙ´²Ñо¿Åú×¢ £¬ÖðÈÕÈý´Î £¬Ã¿´ÎÔö²¹100ºÁ¿ËPS £¬Ò»Á¬·þÓÃ12ÖÜ £¬ÄÜÏÔÖø¸ÄÉÆAD»¼ÕßµÄÈÏÖª¹¦Ð§ºÍÓ°ÏóÁ¦¡£Í¬Ê± £¬½«300ºÁ¿ËPSÓë240ºÁ¿ËPAÍŽáʹÓà £¬Ò²ÏÔʾ³ö¶Ô¸ÄÉÆ»¼ÕßÇéÐ÷ºÍÒ»Ñùƽ³£ÉúÑÄÖÊÁ¿µÄÆð¾¢Ð§¹û¡£


×¢ÖØÁ¦È±ÏݶදÕϰ­£¨ADHD£©¼´¶à¶¯Ö¢ÊÇÒ»ÖÖÉñ¾­·¢ÓýÕϰ­ £¬ÌØÕ÷ÌåÏÖÎª×¢ÖØÁ¦²»¼¯ÖÐ £¬Ò×¼¤¶¯ £¬Ì«¹ý»îÔ¾µÈ¡£ÏÖÔÚÓÃÓÚÖÎÁÆADHDµÄÒ©Îï £¬²¢²»ÊÇËùÓжùͯ¶¼ÄÜÓÐÏìÓ¦»òÄÍÊÜ £¬HirayamaÍŶÓÁÙ´²Ñо¿·¢Ã÷ £¬Ò»Á¬2¸öÔÂÌìÌìÔö²¹200 ºÁ¿Ë PS £¬¿ÉÒÔÏÔÖø¸ÄÉÆADHD¶ùͯµÄÕûÌåÖ¢×´ºÍ¶ÌÆÚÌý¾õÓ°Ïó¡£


Á×Ö¬õ£Ë¿°±ËáÊÇÒ»ÖÖÔÚÈËÌåÄÚ×ÔÈ»±£´æµÄÁ×Ö¬ÓªÑøËØ £¬ÓÈÆäÔÚ´óÄÔ¡¢·Î¡¢ÐÄÔà¡¢¸ÎÔàºÍ¹Ç÷À¼¡µÈ´úл»îÔ¾µÄÆ÷¹ÙÖк¬Á¿¸»ºñ¡£PSÄÜÓë¶àÖÖÂѰ×ÖÊÍÅ½á £¬¼ÓÈëµ÷¿Ø¶àÖÖÉúÎïÀú³Ì £¬°üÀ¨Ã¸µÄ¼¤»î¡¢Ï¸°ûµÄµòÍöÒÔ¼°Éñ¾­ÐźŵÄת´ïµÈ¡£Ôö²¹PS²»µ«¹ØÓÚÖÎÁÆÖÐÊàÉñ¾­ÏµÍ³¼²²¡Èç°¢¶û´Äº£Ä¬²¡ÓÐÆð¾¢×÷Óà £¬»¹ÔÚ°©Ö¢ÖÎÁÆÖÐÏÔʾ³öDZÁ¦ £¬»¹ÆÕ±éÓ¦ÓÃÓÚÓªÑøÑ§ÁìÓò £¬ÀýÈç¸ÄÉÆÇéÐ÷ºÍ¿µ½¡×´Ì¬ £¬Ìá¸ßÈÏÖª¹¦Ð§ºÍÔ˶¯ÌåÏÖ £¬»º½â¼¡ÈâËáÍ´ £¬¸ÄÉÆË¯Ãߵȡ£


ThorntonÍŶӵÄÑо¿Ð§¹ûÅú×¢ £¬Ôö²¹PSÄÜÓÐÓøÄÉÆÄêÇ῵½¡´óѧÉúµÄÈÏÖª¹¦Ð§ £¬ÏêϸÌåÏÖΪÅÌËãËÙÂÊÌá¸ß20% £¬¹ýʧ×ÜÁ¿ïÔÌ­39% £¬×¼È·ÅÌËã×ÜÁ¿Ìá¸ß13%¡£


±ðµÄ £¬PS»¹Äܹ»ÔöÇ¿¸öÌåµÄ¿¹Ñ¹ÄÜÁ¦ £¬²¢¼õ»ºÌ«¹ýÔ˶¯´øÀ´µÄÐÄÀíѹÁ¦¡£Â½æ¯æ¯ºÍ°²ÑàµÈÑо¿Õߵķ¢Ã÷ÏÔʾ £¬¸ßˮƽÉä»÷ÔË·¢¶¯ÔÚ½ÇÖðǰÔö²¹800mg/dµÄPS £¬Äܹ»Í¨¹ý½µµÍƤÖÊ´¼Ë®Æ½¡¢¸ÄÉÆÐľ³ºÍ˯ÃßÖÊÁ¿ £¬´Ó¶øÌáÉýÐÄÀíÓ¦¼¤Ë³Ó¦ÄÜÁ¦¡£


×ÛÉÏËùÊö £¬PSÔÚҽѧºÍÓªÑøÑ§ÁìÓòÓÐ×ÅÆÕ±éµÄÓ¦Óà £¬È»¶ø £¬´Ó´ó¶¹»ò¶¯ÎïÔàÆ÷ÖкÜÄÑ»ñµÃ¼òµ¥ÇҸߴ¿¶ÈµÄPS £¬¼òµ¥»¯Ñ§½á¹¹µÄ¸ß´¿¶ÈPSͨ³£ÐèÒª»¯Ñ§ºÏ³É·¨Éú²ú»ñµÃ¡£ÎÒÃǹ«Ë¾Äܹ»Ïò¿ÆÑÐÊÂÇéÕßÌṩÖÖÖָߴ¿¶ÈµÄÁ×Ö¬õ£Ë¿°±Ëá £¬»¶Ó­ÓÐÐèÇóµÄÅóÙ­À´µç´¹Ñ¯£¡


±íÒ» WilliamHill¹Ù·½ÍøÕ¾ÉúÎï¿ÉÒÔÌṩµÄÏà¹Ø²úÆ·

±í¸ñÅäͼ.jpg




²Î¿¼ÎÄÏ×£º

[1] Wang, J.; Yu, C.X.; Qi, J.X.; et al. The role of phosphatidylserine on the membrane in immunity and blood coagulation[J]. Biomark Res. 2022, 10, 4.

[2] Kay, J.G.; Fairn, G.D.; Distribution, dynamics and functional roles of phosphatidylserine within the cell[J]. Cell Commun Signal. 2019, 17, 126.

[3] Shlomovitz, I.; Speir, M.; Gerlic, M. Flipping the dogma-phosphatidylserine in non-apoptotic cell death[J]. Cell Commun Signal. 2019, 17, 139.

[4] Chang, W.G.; Fa, H.G.; Xiao, D.D.; Wang, J.X. Targeting phosphatidylserine for Cancer therapy: prospects and challenges[J]. Theranostics. 2020, 10, 9214-9229.

[5] ËÎÊçÁÁ, ¼ª°®¹ú. Á×Ö¬õ£Ë¿°±ËáµÄÖÐÊàÉñ¾­×÷ÓÃ[J]. ÖйúÉú»¯Ò©ÎïÔÓÖ¾. 2006, 27, 117-119.

[6] Ma, X.H.; Li, X.J.; Miao, Z.G.; et, al. Phosphatidylserine, inflammation, and central nervous system diseases[J]. Front. Aging Neurosci. 2022, 14, 975176.

[7] Hirayama, S.; Terasawa, K.; J?ger, R.; et al. The effect of phosphatidylserine administration on memory and symptoms of attention- deficit hyperactivity disorder: a randomised, double-blind, placebo- controlled clinical trial[J]. J. Hum. Nutr. Diet. 2013, 27, 284-291.

[8] Starks, M.A.; Starks, S.L.; J?ger, R.; et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise[J]. J Int Soc Sports Nutr. 2008, 5, 11.

[9] Parker, A.G.; Gordon, J.; Kreider, R.D.; et al. The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise[J]. J Int Soc Sports Nutr. 2011, 8, 16.

[10] J?ger, R.; Purpura, M.; Herwegen, H.; et al. The effect of phosphatidylserine on golf performance[J]. J Int Soc Sports Nutr. 2007, 4, 23.

[11] ½½¿½¿, °²Ñà, Ðíèª, ³ÂÓÀÇ¿. Á×Ö¬õ£Ë¿°±Ëá¶ÔÉä»÷ÔË·¢¶¯ÐÄÀíÓ¦¼¤Ë³Ó¦ÄÜÁ¦¼°ÄÔÄÚÉñ¾­µÝÖʼ¤»îˮƽµÄÓ°Ïì[J]. ÓªÑøÑ§±¨. 2019, 41, 439-443.


ÍøÕ¾µØÍ¼